【巨星医疗控股(02393.HK)：非执行董事何震发所持约2.68亿股公司股份被接管】巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。

金融界2025-01-21

巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2505027833?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-21 21:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505027833","market":"us","top_or_hot":-1,"title":"【巨星医疗控股(02393.HK)：非执行董事何震发所持约2.68亿股公司股份被接管】巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。","media":"金融界","content":"<div>\n<p>巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/01/21212747676808.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【巨星医疗控股(02393.HK)：非执行董事何震发所持约2.68亿股公司股份被接管】巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【巨星医疗控股(02393.HK)：非执行董事何震发所持约2.68亿股公司股份被接管】巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-21 21:27 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/01/21212747676808.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/01/21212747676808.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0300736492.USD","symbol_name":"FRANKLIN NATURAL RESOURCES \"A\" (USD) INC","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/01/21212747676808.shtml","article_id":"2505027833","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505027833","pubTimestamp":1737466077,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0300736492.USD":"FRANKLIN NATURAL RESOURCES \"A\" (USD) INC","BK4179":"石油天然气设备与服务","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","BK1222":"医疗保健用品","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","FTI":"德希尼布FMC","LU0300736062.USD":"FRANKLIN NATURAL RESOURCES \"A\" (USD) ACC","02393":"巨星医疗控股"},"translate_title":"[Superstar Medical Holdings (02393. HK): About 268 million shares of the company held by non-executive director He Zhenfa were taken over] Superstar Medical Holdings (02393. HK) announced that on January 21, 2025, the board of directors received Huo Xiyu from FTI Consulting Mr. and Mr. Zhou Weicheng (receiver, They were appointed as joint and separate receivers of approximately 268 million ordinary shares (charged shares) of the company held by Mr. He Zhenfa, a non-executive director of the company. The charged shares accounted for approximately 11.49% of the total issued shares of the company","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FTI":1,"02393":1},"content_text":"巨星医疗控股(02393.HK)公布，于2025年1月21日，董事会收到FTI Consulting的霍羲禹先生及周伟成先生(接管人，彼等获委任为公司非执行董事何震发先生所持约2.68亿股公司普通股(已押记股份)的联席及各别接管人)发出的函件。已押记股份占于本公告日期公司已发行股份总数约11.49%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2505027833","isCrawlerRequest":true}